Globally, the COVID-19 pandemic has had a significant impact, given the rise in the demand for novel therapeutics such as vaccines that can be used in the treatment of COVID-19 patients.Compared to other regions of the world, gross vaccine inequity exists in Africa due to several factors tied to the acute lack of vaccines in thumper v2 price the region.As a result, efforts are currently being made to ramp up the production of COVID-19 vaccines in the region.
However, there are concerns that most countries in Africa lack the adequate pharmaceutical manufacturing capacity required to produce COVID-19 vaccines, and Zimbabwe is not an exception.This article, therefore, aims to evaluate the preparedness and readiness efforts of the Zimbabwean pharmaceutical andre 3000 new blue sun zip industry in the production of COVID-19 vaccines.